Status:
RECRUITING
Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.
Lead Sponsor:
Castagna Antonella
Collaborating Sponsors:
ViiV Healthcare
Conditions:
HIV-1-infection
Multi-Antiviral Resistance
Eligibility:
All Genders
14+ years
Brief Summary
The PRESTIGIO Registry is an Observational, prospective, multicentre study that includes patients, regularly followed by Italian Infectious Disease Centres, with HIV-1 infection and documented resista...
Detailed Description
The PRESTIGIO Register consists of a systematic and continuous collection of data on clinical, laboratory and treatment characteristics of patients with documented resistance to the 4 classes of antir...
Eligibility Criteria
Inclusion
- subjects with HIV-1 infection;
- age \>14 years;
- documented resistance to the 4 classes of antiretroviral drugs (NRTI, NNRTI, PI, INI), defined as resistance (at least intermediate) to at least one of the drugs in each class according to the Stanford algorithm. Resistance can be documented either at the time of inclusion in the study or previously documented throughout the patient's therapeutic history.
Exclusion
- none
Key Trial Info
Start Date :
December 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04098315
Start Date
December 14 2017
End Date
December 31 2028
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale San Raffaele
Milan, MI, Italy, 20127